Cargando…
Canagliflozin attenuates lipotoxicity in cardiomyocytes and protects diabetic mouse hearts by inhibiting the mTOR/HIF-1α pathway
Lipotoxicity plays an important role in the development of diabetic heart failure (HF). Canagliflozin (CAN), a marketed sodium-glucose co-transporter 2 inhibitor, has significantly beneficial effects on HF. In this study, we evaluated the protective effects and mechanism of CAN in the hearts of C57B...
Autores principales: | Sun, Pengbo, Wang, Yangyang, Ding, Yipei, Luo, Jingyi, Zhong, Jin, Xu, Naihan, Zhang, Yaou, Xie, Weidong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8188479/ https://www.ncbi.nlm.nih.gov/pubmed/34142035 http://dx.doi.org/10.1016/j.isci.2021.102521 |
Ejemplares similares
-
Canagliflozin Attenuates Lipotoxicity in Cardiomyocytes by Inhibiting Inflammation and Ferroptosis through Activating AMPK Pathway
por: Zhang, Wanqiu, et al.
Publicado: (2023) -
Canagliflozin Modulates Hypoxia-Induced Metastasis, Angiogenesis and Glycolysis by Decreasing HIF-1α Protein Synthesis via AKT/mTOR Pathway
por: Luo, Jingyi, et al.
Publicado: (2021) -
Empagliflozin-Enhanced Antioxidant Defense Attenuates Lipotoxicity and Protects Hepatocytes by Promoting FoxO3a- and Nrf2-Mediated Nuclear Translocation via the CAMKK2/AMPK Pathway
por: Wang, Yangyang, et al.
Publicado: (2022) -
Intragastric and atomized administration of canagliflozin inhibit inflammatory cytokine storm in lipopolysaccharide-treated sepsis in mice: A potential COVID-19 treatment
por: Niu, Yaoyun, et al.
Publicado: (2021) -
Canagliflozin Delays Aging of HUVECs Induced by Palmitic Acid via the ROS/p38/JNK Pathway
por: Hao, Wenhui, et al.
Publicado: (2023)